STUMPTOWN STRATEGIES

Lobbying for PRIME THERAPEUTICS · Healthcare

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Minnesota · House · Senate · $20,000.00 income · posted Jan 19, 2026

Bills named in this filing 1

Lobbying activity 2

Health Issues

PBM issues - Transparency, Delinking HR 2214 Drug Act

Pharmacy

HR 2214 DRUG Act Delinking, PBM Issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.